Tiaa, Fsb Vertex Pharmaceuticals Inc Transaction History

Tiaa, Fsb

$27.6 Billion
Q2 2023

A detailed history of Tiaa, Fsb transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Tiaa, Fsb holds 5,227 shares of VRTX stock, worth $2.53 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,227

Previous 5,150 1.5%

Holding current value

$2.53 Million

Previous $1.62 Million 13.38%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	BUY	$314.42 - $351.91 $24,210 - $27,097	77 Added 1.5%	5,227 $1.84 Million
Q1 2023 Apr 19, 2023	SELL	$283.23 - $323.1 $72,223 - $82,390	-255 Reduced 4.72%	5,150 $1.62 Million
Q4 2022 Jan 12, 2023	BUY	$285.76 - $321.48 $86,585 - $97,408	303 Added 5.94%	5,405 $1.56 Million
Q3 2022 Oct 11, 2022	SELL	$273.83 - $305.53 $101,864 - $113,657	-372 Reduced 6.8%	5,102 $1.48 Million
Q2 2022 Aug 09, 2022	BUY	$234.96 - $292.55 $1.29 Million - $1.6 Million	5,474 New	5,474 $1.54 Million
Q4 2019 Jan 13, 2020	SELL	$166.71 - $223.91 $6.02 Million - $8.09 Million	-36,118 Closed	0 $0
Q3 2019 Oct 08, 2019	SELL	$166.23 - $187.09 $6.87 Million - $7.73 Million	-41,307 Reduced 53.35%	36,118 $6.12 Million
Q2 2019 Aug 14, 2019	BUY	$164.61 - $190.37 $4.68 Million - $5.41 Million	28,424 Added 58.01%	77,425 $14.2 Million
Q1 2019 Apr 15, 2019	BUY	$163.73 - $194.7 $360,042 - $428,145	2,199 Added 4.7%	49,001 $9.01 Million
Q4 2018 Apr 15, 2019	BUY	$151.91 - $192.21 $7.11 Million - $9 Million	46,802 New	46,802 $7.76 Million
Q4 2018 Feb 22, 2019	SELL	$151.91 - $192.21 $6.73 Million - $8.52 Million	-44,324 Closed	0 $0
Q3 2018 Oct 18, 2018	BUY	$167.73 - $192.74 $668,068 - $767,683	3,983 Added 9.87%	44,324 $8.54 Million
Q2 2018 Jul 20, 2018	BUY	$145.72 - $169.96 $5.88 Million - $6.86 Million	40,341 New	40,341 $6.86 Million

Others Institutions Holding VRTX

# of Institutions

1,717

Shares Held

222M

Call Options Held

1.5M

Put Options Held

1.31M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $124B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tiaa, Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Tiaa, Fsb with notifications on news.

Account